A detailed history of Ramsay, Stattman, Vela & Price, Inc. transactions in Danaher Corp stock. As of the latest transaction made, Ramsay, Stattman, Vela & Price, Inc. holds 68,552 shares of DHR stock, worth $15.8 Million. This represents 3.63% of its overall portfolio holdings.

Number of Shares
68,552
Previous 69,988 2.05%
Holding current value
$15.8 Million
Previous $17.5 Million 8.98%
% of portfolio
3.63%
Previous 3.37%

Shares

30 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 25, 2024

SELL
$239.25 - $280.76 $343,563 - $403,171
-1,436 Reduced 2.05%
68,552 $19.1 Million
Q2 2024

Jul 31, 2024

SELL
$235.51 - $267.98 $49,692 - $56,543
-211 Reduced 0.3%
69,988 $17.5 Million
Q1 2024

May 01, 2024

SELL
$224.58 - $256.19 $151,366 - $172,672
-674 Reduced 0.95%
70,199 $17.5 Million
Q4 2023

Feb 01, 2024

BUY
$185.1 - $233.13 $282,832 - $356,222
1,528 Added 2.2%
70,873 $16.4 Million
Q3 2023

Oct 27, 2023

SELL
$233.08 - $265.59 $423,506 - $482,577
-1,817 Reduced 2.55%
69,345 $17.2 Million
Q2 2023

Jul 31, 2023

BUY
$224.99 - $256.14 $986,581 - $1.12 Million
4,385 Added 6.57%
71,162 $17.1 Million
Q1 2023

Apr 28, 2023

BUY
$239.75 - $277.0 $60,896 - $70,358
254 Added 0.38%
66,777 $16.8 Million
Q4 2022

Feb 03, 2023

SELL
$241.42 - $282.29 $7,725 - $9,033
-32 Reduced 0.05%
66,523 $17.7 Million
Q3 2022

Oct 28, 2022

SELL
$247.06 - $1507.4 $172,942 - $1.06 Million
-700 Reduced 1.04%
66,555 $17.2 Million
Q2 2022

Aug 04, 2022

BUY
$237.11 - $299.66 $22,762 - $28,767
96 Added 0.14%
67,255 $17.1 Million
Q1 2022

May 12, 2022

SELL
$257.27 - $315.76 $590,691 - $724,984
-2,296 Reduced 3.31%
67,159 $19.7 Million
Q4 2021

Jan 24, 2022

SELL
$292.08 - $329.01 $541,516 - $609,984
-1,854 Reduced 2.6%
69,455 $22.9 Million
Q3 2021

Oct 29, 2021

SELL
$272.21 - $332.43 $181,291 - $221,398
-666 Reduced 0.93%
71,309 $21.7 Million
Q2 2021

Jul 28, 2021

SELL
$225.08 - $271.69 $154,179 - $186,107
-685 Reduced 0.94%
71,975 $19.3 Million
Q1 2021

Apr 22, 2021

SELL
$212.38 - $245.9 $182,434 - $211,228
-859 Reduced 1.17%
72,660 $16.4 Million
Q4 2020

Jan 26, 2021

SELL
$212.5 - $245.46 $309,187 - $357,144
-1,455 Reduced 1.94%
73,519 $16.3 Million
Q3 2020

Nov 09, 2020

SELL
$177.16 - $215.33 $35,254 - $42,850
-199 Reduced 0.26%
74,974 $16.1 Million
Q2 2020

Aug 04, 2020

SELL
$128.7 - $176.83 $376,447 - $517,227
-2,925 Reduced 3.75%
75,173 $13.3 Million
Q1 2020

May 04, 2020

SELL
$121.39 - $169.05 $107,308 - $149,440
-884 Reduced 1.12%
78,098 $10.8 Million
Q4 2019

Jan 28, 2020

SELL
$133.47 - $153.48 $107,309 - $123,397
-804 Reduced 1.01%
78,982 $12.1 Million
Q3 2019

Nov 07, 2019

SELL
$135.4 - $146.47 $103,445 - $111,903
-764 Reduced 0.95%
79,786 $11.5 Million
Q2 2019

Aug 09, 2019

SELL
$124.88 - $143.73 $429,087 - $493,856
-3,436 Reduced 4.09%
80,550 $11.5 Million
Q1 2019

May 07, 2019

SELL
$97.62 - $132.29 $34,655 - $46,962
-355 Reduced 0.42%
83,986 $11.1 Million
Q4 2018

Feb 05, 2019

SELL
$94.85 - $109.54 $77,302 - $89,275
-815 Reduced 0.96%
84,341 $8.7 Million
Q3 2018

Oct 30, 2018

BUY
$98.13 - $108.9 $104,017 - $115,434
1,060 Added 1.26%
85,156 $9.25 Million
Q2 2018

Aug 01, 2018

BUY
$96.1 - $103.24 $6,534 - $7,020
68 Added 0.08%
84,096 $8.3 Million
Q1 2018

May 01, 2018

BUY
$92.16 - $103.8 $50,688 - $57,090
550 Added 0.66%
84,028 $8.23 Million
Q4 2017

Jan 30, 2018

SELL
$85.26 - $94.62 $30,267 - $33,590
-355 Reduced 0.42%
83,478 $7.75 Million
Q3 2017

Oct 30, 2017

BUY
$79.29 - $88.45 $440,693 - $491,605
5,558 Added 7.1%
83,833 $7.19 Million
Q2 2017

Aug 07, 2017

BUY
N/A
78,275
78,275 $6.61 Million

Others Institutions Holding DHR

About DANAHER CORP


  • Ticker DHR
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 727,963,008
  • Market Cap $168B
  • Description
  • Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The company operates through three segments: Life Sciences, Diagnostics, and Environmental & Applied Solutions. The Life Sciences segment provides mass spectrometers; flow cytometry, genomics, lab automati...
More about DHR
Track This Portfolio

Track Ramsay, Stattman, Vela & Price, Inc. Portfolio

Follow Ramsay, Stattman, Vela & Price, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ramsay, Stattman, Vela & Price, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Ramsay, Stattman, Vela & Price, Inc. with notifications on news.